Welcome to our dedicated page for Balchem Corporation news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem Corporation stock.
Founded in 1967, Balchem Corporation (NASDAQ: BCPC) offers innovative solutions and high-quality products across various industries globally. The company operates through four principal segments: Human Nutrition & Health, Specialty Products, Animal Nutrition & Health, and Industrial Products.
In the Human Nutrition & Health segment, Balchem provides essential choline nutrients and mineral amino acid chelates, supporting diverse health and nutritional applications. Their Animal Nutrition & Health segment delivers nutritional products derived from advanced microencapsulation and chelation technologies, alongside critical nutrient choline chloride, aimed at enhancing animal health.
The Specialty Products segment involves the repackaging and distribution of performance gases and chemicals, such as ethylene oxide, propylene oxide, and ammonia, for various industrial uses. Additionally, Balchem's Industrial Products segment caters to a broad range of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, agricultural, and medical sterilization industries.
Balchem employs approximately 1,000 people globally who are committed to driving the company into market leadership positions. Recent company achievements include their first professional sports partnership for VitaCholine®, spanning regions like the United States and the United Kingdom.
Balchem's dedication to research is evident in collaborations and studies, such as those exploring improved visuomotor performance through choline supplementation. The company's financial health and strategic growth initiatives continue to position it favorably within its chosen markets.
For more information, visit the Balchem Corporation website and stay updated with their latest news and developments.
Balchem Corporation (NASDAQ: BCPC) has declared a dividend of $0.64 per share, marking a 10.3% increase from the previous year. This dividend will be payable on January 21, 2022, to stockholders of record by December 28, 2021. CEO Ted Harris highlighted this as the thirteenth consecutive increase in dividends, showcasing the company's strong financial performance and the Board’s confidence in its long-term strategies. Balchem is known for its specialty ingredients that enhance health across various industries.
Balchem Corporation (NASDAQ: BCPC) will participate in the Virtual Stephens Annual Investment Conference on November 29, 2021. The company's leadership, including CEO Ted Harris and CFO Martin Bengtsson, will represent Balchem at this significant investment event. Balchem specializes in developing and marketing specialty ingredients, categorized into three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. Their offerings enhance health across various industries, including food, supplements, and pharmaceuticals.
Balchem Corporation (NASDAQ: BCPC) will be represented by its Chairman and CEO, Ted Harris, and CFO, Martin Bengtsson, at the Baird 2021 Global Industrial Conference on November 10, 2021. The presentation will be accessible on Balchem's investor relations website after the event. Balchem specializes in developing and marketing ingredients that enhance health and well-being across various industries, with three main segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) reported record third quarter net earnings of $25 million for 2021, up from $21.6 million in Q3 2020. Adjusted net earnings reached $30 million, a rise of 11.3%, and net sales were $197.9 million, reflecting a 13% increase. Each business segment reported record sales, driven by strong performance in Human Nutrition & Health and Animal Nutrition & Health. Adjusted EBITDA improved to $48.3 million, an 8.8% increase. Cash flows from operations were $39.6 million, with free cash flow at $31.1 million, demonstrating robust financial health amidst economic challenges.
Balchem Corporation (NASDAQ: BCPC) will hold a conference call on October 29, 2021, at 11:00 AM ET to discuss its third quarter results. The results will be released before the market opens on the same day. Participants can access the call by dialing 1-877-407-8289 (local 1-201-689-8341) five minutes prior to the start. A replay of the call will be available until November 12, 2021. Balchem specializes in nutritional ingredients across multiple sectors including animal and human health.
Balchem Corporation (NASDAQ: BCPC) reported record second quarter net earnings of $22.7 million for 2021, a 7.6% increase from $21.1 million in Q2 2020. Adjusted net earnings rose to $30.4 million, up 10.3%. Net sales reached $202.4 million, a 16.7% increase driven by growth in all segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Despite experiencing a $3.8 million loss from a flash flood event, cash flows remained strong with $35.8 million from operations. The effective tax rate increased to 24.3% from 18.7% in the prior year.
Balchem Corporation (NASDAQ: BCPC) is set to present at the Jefferies Virtual Industrials Conference on August 4, 2021, starting at 9:00 a.m. ET. The presentation will be led by Chairman and CEO Ted Harris, along with CFO Martin Bengtsson. Investors and interested parties can listen to the presentation via the provided link.
Balchem specializes in developing, manufacturing, and marketing ingredients aimed at improving health across various industries, including Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) will hold a conference call on July 30, 2021, at 11:00 AM ET to discuss its second quarter results. The results will be published before the market opens on the same day. The conference call, hosted by Ted Harris (CEO) and Martin Bengtsson (CFO), will be available for replay until August 13, 2021. Interested parties can access the call by dialing toll-free 1-877-407-8289. More details including financial exhibits will be available on balchem.com.
Balchem Corporation (NASDAQ: BCPC) will present at the Stephens Food & Ag Disrupted: Public-Private Conference on May 25, 2021, starting at 9:00 a.m. (ET). Chairman and CEO Ted Harris and CFO Martin Bengtsson will lead the presentation. Investors can follow the link to listen live: Presentation Link.
Balchem develops specialty ingredients across three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, enhancing health and well-being globally.
Balchem Corporation (NASDAQ: BCPC) reported strong first-quarter 2021 financial results, achieving net earnings of $23.4 million, up 18.4% year-over-year. Adjusted net earnings also rose to $28.4 million, reflecting growth across all three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Net sales increased by 6.4% to $185.7 million, with notable contributions from chelated minerals and choline nutrients. The company maintained strong cash flow, leading to $40.6 million in operational cash flow and $34.4 million in free cash flow.
FAQ
What is the current stock price of Balchem Corporation (BCPC)?
What is the market cap of Balchem Corporation (BCPC)?
What industries does Balchem Corporation serve?
What are the main segments of Balchem Corporation?
What products are offered in the Human Nutrition & Health segment?
How does the Animal Nutrition & Health segment contribute to Balchem's portfolio?
What performance gases and chemicals are included in Balchem's Specialty Products segment?
How many employees does Balchem Corporation have?
What recent achievements has Balchem Corporation made?
Where can I find more information about Balchem Corporation?
How does Balchem contribute to research?
What is Balchem's market position?
